Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antidepressant-like effect of mitragynine isolated from Mitragyna speciosa Korth in mice model of depression
N. Farah Idayu, Mohamad Taufik Hidayat, Mohamad Aris Mohd Moklas, et al.
Phytomedicine (2010) Vol. 18, Iss. 5, pp. 402-407
Open Access | Times Cited: 161

Showing 26-50 of 161 citing articles:

Evaluation of the Cardiotoxicity of Mitragynine and Its Analogues Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Jun Lü, Heming Wei, Jian Wu, et al.
PLoS ONE (2014) Vol. 9, Iss. 12, pp. e115648-e115648
Open Access | Times Cited: 67
Discriminative stimulus properties of mitragynine (kratom) in rats
Norsyifa Harun, Zurina Hassan, Visweswaran Navaratnam, et al.
Psychopharmacology (2015) Vol. 232, Iss. 13, pp. 2227-2238
Closed Access | Times Cited: 65
Current standing of plant derived flavonoids as an antidepressant
Haroon Khan, Sadia Perviz, Antoni Sureda, et al.
Food and Chemical Toxicology (2018) Vol. 119, pp. 176-188
Closed Access | Times Cited: 65
Mitragynine Attenuates Morphine Withdrawal Effects in Rats—A Comparison With Methadone and Buprenorphine
Rahimah Hassan, Pike-See Cheah, Sreenivasan Sasidharan, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 61
Mitragyna speciosa: Clinical, Toxicological Aspects and Analysis in Biological and Non-Biological Samples
Vânia Meireles, Tiago Rosado, Mário Barroso, et al.
Medicines (2019) Vol. 6, Iss. 1, pp. 35-35
Open Access | Times Cited: 60
Natural products for the treatment of stress-induced depression: Pharmacology, mechanism and traditional use
Wei Dai, Kunmiao Feng, Xiaolei Sun, et al.
Journal of Ethnopharmacology (2021) Vol. 285, pp. 114692-114692
Closed Access | Times Cited: 51
Medicinal Plants in the Treatment of Depression: Evidence from Preclinical Studies
Inés Moragrega, José Luis Rı́os
Planta Medica (2021) Vol. 87, Iss. 09, pp. 656-685
Open Access | Times Cited: 41
Clinical Implications of Kratom (Mitragyna speciosa) Use: a Literature Review
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 317-334
Open Access | Times Cited: 17
Mitragynine Attenuates Withdrawal Syndrome in Morphine-Withdrawn Zebrafish
Beng-Siang Khor, Mohd Fadzly Amar Jamil, Mohamad Ilham Adenan, et al.
PLoS ONE (2011) Vol. 6, Iss. 12, pp. e28340-e28340
Open Access | Times Cited: 73
Biochemical Benefits, Diagnosis, and Clinical Risks Evaluation of Kratom
Dimy Fluyau, Neelambika Revadigar
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 60
Acute Treatment with a Novel TRPC4/C5 Channel Inhibitor Produces Antidepressant and Anxiolytic-Like Effects in Mice
Li-Ping Yang, Fang-Jie Jiang, Gui-Sheng Wu, et al.
PLoS ONE (2015) Vol. 10, Iss. 8, pp. e0136255-e0136255
Open Access | Times Cited: 59
Anxiolytic-like effects of mitragynine in the open-field and elevated plus-maze tests in rats
Ammar Imad Hazim, Surash Ramanathan, Suhanya Parthasarathy, et al.
The Journal of Physiological Sciences (2014) Vol. 64, Iss. 3, pp. 161-169
Open Access | Times Cited: 56
Antidepressants: Mechanism of Action, Toxicity and Possible Amelioration
Bechan Sharma
Journal of Applied Biotechnology & Bioengineering (2017) Vol. 3, Iss. 5
Open Access | Times Cited: 56
Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs
Zurina Hassan, Oliver G. Bosch, Darshan Singh, et al.
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 52
Antidepressant-like effects of rosmarinic acid through mitogen-activated protein kinase phosphatase-1 and brain-derived neurotrophic factor modulation
Shinji Kondo, Abdelfatteh El Omri, Junkyu Han, et al.
Journal of Functional Foods (2015) Vol. 14, pp. 758-766
Open Access | Times Cited: 51
Self-reported Health Diagnoses and Demographic Correlates With Kratom Use: Results From an Online Survey
Rhiannon Bath, Tanner Bucholz, Amy Buros, et al.
Journal of Addiction Medicine (2019) Vol. 14, Iss. 3, pp. 244-252
Open Access | Times Cited: 49
Chronic mitragynine (kratom) enhances punishment resistance in natural reward seeking and impairs place learning in mice
Nurul Iman Ismail, Nanthini Jayabalan, Sharif Mahsufi Mansor, et al.
Addiction Biology (2016) Vol. 22, Iss. 4, pp. 967-976
Closed Access | Times Cited: 47
Correlations of kratom (Mitragyna speciosa Korth.) use behavior and psychiatric conditions from a cross-sectional survey.
Oliver Grundmann, Charles A. Veltri, Sara Morcos, et al.
Experimental and Clinical Psychopharmacology (2023) Vol. 31, Iss. 5, pp. 963-977
Open Access | Times Cited: 14
Antidepressant-like behavioral, neurochemical and neuroendocrine effects of naringenin in the mouse repeated tail suspension test
Li‐Tao Yi, Jing Li, Huo-Chen Li, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2012) Vol. 39, Iss. 1, pp. 175-181
Closed Access | Times Cited: 56
Orally Active Opioid Compounds from a Non-Poppy Source
Robert B. Raffa, Jaclyn R. Beckett, Vivek N. Brahmbhatt, et al.
Journal of Medicinal Chemistry (2013) Vol. 56, Iss. 12, pp. 4840-4848
Closed Access | Times Cited: 45
Pharmacokinetics of mitragynine, a major analgesic alkaloid in kratom (Mitragyna speciosa): A systematic review
Kimheang Ya, Wimonchat Tangamornsuksan, C. Norman Scholfield, et al.
Asian Journal of Psychiatry (2019) Vol. 43, pp. 73-82
Closed Access | Times Cited: 42
Biomedical analysis of New Psychoactive Substances (NPS) of natural origin
Alfredo Fabrizio Lo Faro, Annagiulia Di Trana, Nunzia La Maida, et al.
Journal of Pharmaceutical and Biomedical Analysis (2019) Vol. 179, pp. 112945-112945
Closed Access | Times Cited: 41
Antidepressant potential of Uncaria rhynchophylla and its active flavanol, catechin, targeting melatonin receptors
Chang‐An Geng, Tonghua Yang, Xiaoyan Huang, et al.
Journal of Ethnopharmacology (2018) Vol. 232, pp. 39-46
Closed Access | Times Cited: 40
Mitragyna speciosa Leaf Extract Exhibits Antipsychotic-Like Effect with the Potential to Alleviate Positive and Negative Symptoms of Psychosis in Mice
Kamini Vijeepallam, Vijayapandi Pandy, Thubasni Kunasegaran, et al.
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 39
The Potential for Kratom as an Antidepressant and Antipsychotic.
Lindsay E Johnson, Lilian Balyan, Amy Magdalany, et al.
(2020) Vol. 93, Iss. 2, pp. 283-289
Closed Access | Times Cited: 37

Scroll to top